4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-007942
SVP, COO & CFO sold 150,000 shares at an average $19.86 ($2,979,629)
- SVP, COO & CFO acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Labrucherie Gil M · SVP, COO & CFO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-02 | Exercise or conversion : show line 1 in the form | +50,000 | $8.80 | $440,000 | 316,973 | D |
| 2021-02-02 | Sale : show line 2 in the form | −41,135 | $19.97 | $821,466 | 275,838 | D |
| 2021-02-02 | Sale : show line 3 in the form | −6,932 | $20.96 | $145,295 | 268,906 | D |
| 2021-02-02 | Sale : show line 4 in the form | −1,933 | $21.66 | $41,869 | 266,973 | D |
| 2021-02-03 | Exercise or conversion : show line 5 in the form | +25,000 | $8.80 | $220,000 | 291,973 | D |
| 2021-02-03 | Exercise or conversion : show line 6 in the form | +25,000 | $8.80 | $220,000 | 316,973 | D |
| 2021-02-03 | Sale : show line 7 in the form | −50,000 | $19.61 | $980,500 | 266,973 | D |
| 2021-02-04 | Exercise or conversion : show line 8 in the form | +50,000 | $8.80 | $440,000 | 316,973 | D |
| 2021-02-04 | Sale : show line 9 in the form | −50,000 | $19.81 | $990,500 | 266,973 | D |
| Open-market sales · 150,000 sh · avg $19.86 · $2,979,629 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-02 | Exercise or conversion : show line 10 in the form Stock Option | −50,000 | 25,000 | D |
| 2021-02-03 | Exercise or conversion : show line 11 in the form Stock Option | −25,000 | 0 | D |
| 2021-02-03 | Exercise or conversion : show line 12 in the form Stock Option | −25,000 | 50,000 | D |
| 2021-02-04 | Exercise or conversion : show line 13 in the form Stock Option | −50,000 | 0 | D |
Loading xslF345X03/doc4.xml…